MREO
Mereo BioPharma Group plc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No N-PORT holders.
—
—
No thesis.
Mereo BioPharma Group plc
0.28
−0.01 · −2.52%
post 0.28 0.00%
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Rubric Capital ManagementRubric | $4.9M | 26.67% | 0.00% | |
| 2 | 683 Capital Management683 Capital Management | $3.7M | 20.52% | −1.85% | |
| 3 | Bank of AmericaBank of America | $2.6M | 14.25% | 0.00% | |
| 4 | Defilade Capital ManagementDefilade | $2.4M | 13.17% | 0.00% | |
| 5 | Newtyn ManagementNewtyn | $953,100 | 5.23% | −57.62% | |
| 6 | Tejara CapitalTejara Capital | $647,320 | 3.55% | 0.00% | |
| 7 | UBS GroupUBS | $460,346 | 2.52% | −2.85% | |
| 8 | Two Sigma InvestmentsTwo Sigma | $419,123 | 2.30% | +602.33% | |
| 9 | Citadel AdvisorsCitadel | $317,719 | 1.74% | +119.89% | |
| 10 | EcoR1 CapitalEcoR1 Capital | $317,700 | 1.74% | −92.52% | |
| 11 | Jane Street GroupJane Street | $249,949 | 1.37% | +135.71% | |
| 12 | Ishara InvestmentsIshara | $244,232 | 1.34% | new | |
| 13 | Sontag AdvisorySontag Advisory | $243,041 | 1.33% | −3.90% | |
| 14 | Susquehanna International GroupSusquehanna International | $137,996 | 0.76% | −2.51% | |
| 15 | Rangeley CapitalRangeley Capital | $104,587 | 0.57% | 0.00% | |
| 16 | Marshall WaceMarshall Wace | $57,563 | 0.32% | −73.82% | |
| 17 | XTX TopcoXTX Topco | $55,433 | 0.30% | +106.56% | |
| 18 | Group One TradingGroup One Trading | $53,220 | 0.29% | −50.12% | |
| 19 | State StreetState Streetindex-like | $42,817 | 0.23% | +1.04% | |
| 20 | Nomura HoldingsNomura | $33,155 | 0.18% | new | |
| 21 | James J. BurnsJames J. Burns | $30,309 | 0.17% | new | |
| 22 | QuarryQuarry | $29,784 | 0.16% | new | |
| 23 | Goldman Sachs GroupGoldman Sachs | $27,062 | 0.15% | new | |
| 24 | JMN FinancialJMN Financial | $24,383 | 0.13% | new | |
| 25 | BlackRockBlackRockindex-like | $22,137 | 0.12% | −77.00% |
57 managers report $18.2M of Mereo BioPharma on form 13F for the quarter ended Jun 30 '26. 6 of them hold 80% of it; Rubric is largest at 26.67%.
Expected move
No implied move.